Stock LTHM LIVENT
Add to a list
To use this feature you must be a member
Log inSign up

Financials LIVENT Nyse

Equities

LTHM

US53814L1089

Specialty Chemicals

Market Closed - Nyse
Other stock markets
 04:00:13 2024-01-03 pm EST 		5-day change 1st Jan Change
16.51 USD -8.53% Intraday chart for LIVENT +140.60% +120.93%
Apr. 09 KeyBanc Trims Price Target on Arcadium Lithium to $11 From $12, Keeps Overweight Rating MT
Apr. 04 Raymond James Upgrades Arcadium Lithium to Strong Buy from Outperform MT

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 1,248 2,756 3,939 3,564 3,235 4,171 - -
Enterprise Value (EV) 1 1,386 2,981 4,067 3,617 3,299 4,008 4,327 4,391
P/E ratio 25.1 x -145 x 7,396 x 14.6 x 4.73 x 13.2 x 6.38 x 4.73 x
Yield - - - - - - - -
Capitalization / Revenue 3.21 x 9.56 x 9.37 x 4.38 x 3.67 x 3.22 x 2.28 x 1.66 x
EV / Revenue 3.57 x 10.3 x 9.67 x 4.45 x 3.74 x 3.1 x 2.36 x 1.75 x
EV / EBITDA 13.9 x 134 x 58.5 x 9.86 x 6.57 x 7.42 x 4.94 x 3.21 x
EV / FCF -11 x -25.3 x -38.5 x 30.7 x -111 x -20.7 x -15.5 x 29 x
FCF Yield -9.11% -3.95% -2.59% 3.26% -0.9% -4.84% -6.44% 3.44%
Price to Book 2.29 x 4.87 x 5.48 x 2.78 x 0.68 x 0.62 x 0.6 x 0.54 x
Nbr of stocks (in thousands) 351,230 352,004 388,749 431,573 432,889 1,075,070 - -
Reference price 2 3.554 7.830 10.13 8.259 7.473 3.880 3.880 3.880
Announcement Date 2/20/20 2/18/21 2/17/22 2/14/23 2/22/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 388.4 288.2 420.4 813.2 882.5 1,295 1,832 2,515
EBITDA 1 99.8 22.3 69.5 366.7 502.5 540.1 876.4 1,368
EBIT 1 78.9 -2.7 44.4 339 472.9 393.7 757.6 1,274
Operating Margin 20.31% -0.94% 10.56% 41.69% 53.59% 30.41% 41.36% 50.67%
Earnings before Tax (EBT) 1 57.8 -25.4 23.9 335.4 389 364.2 640 1,218
Net income 1 50.2 -18.9 0.6 273.5 330.1 274.8 571.1 934.3
Net margin 12.92% -6.56% 0.14% 33.63% 37.41% 21.23% 31.18% 37.15%
EPS 2 0.1413 -0.0540 0.001370 0.5652 1.580 0.2940 0.6080 0.8200
Free Cash Flow 1 -126.2 -117.7 -105.5 117.8 -29.8 -194 -278.5 151.2
FCF margin -32.49% -40.84% -25.1% 14.49% -3.38% -14.98% -15.2% 6.01%
FCF Conversion (EBITDA) - - - 32.12% - - - 11.06%
FCF Conversion (Net income) - - - 43.07% - - - 16.19%
Dividend per Share 2 - - - - - - - -
Announcement Date 2/20/20 2/18/21 2/17/22 2/14/23 2/22/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 103.6 122.9 143.5 218.7 231.6 219.4 253.5 235.8 211.4 181.8 277.3 298.2 335.3 356.1 381
EBITDA 1 14.9 27.5 53.3 95 110.8 107.6 157.4 134.5 119.7 90.9 99.89 112.1 127.7 146.6 160.1
EBIT 1 8.7 21.1 46.9 88.6 104.2 99.3 150.6 127.5 112 82.8 71.2 87.38 99.78 125.5 128.4
Operating Margin 8.4% 17.17% 32.68% 40.51% 44.99% 45.26% 59.41% 54.07% 52.98% 45.54% 25.67% 29.3% 29.76% 35.24% 33.69%
Earnings before Tax (EBT) 1 2.8 17 57.9 90.2 99.1 88.2 138.7 104.8 96.7 48.8 69.38 80.07 85.67 109.2 120
Net income 1 -12.6 7.5 53.2 60 77.6 82.7 114.8 90.2 87.4 37.7 48.34 59.3 68.08 86.08 85.7
Net margin -12.16% 6.1% 37.07% 27.43% 33.51% 37.69% 45.29% 38.25% 41.34% 20.74% 17.43% 19.89% 20.3% 24.17% 22.49%
EPS 2 -0.0332 0.0166 0.1164 0.1288 0.1538 0.1621 0.2286 0.1787 0.1746 0.1800 0.0385 0.0500 0.0600 0.0733 0.0650
Dividend per Share 2 - - - - - - - - - - - - - - -
Announcement Date 11/4/21 2/17/22 5/3/22 8/2/22 11/1/22 2/14/23 5/2/23 8/3/23 10/31/23 2/22/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 138 225 127 52.9 64.4 - 156 220
Net Cash position 1 - - - - - 164 - -
Leverage (Debt/EBITDA) 1.381 x 10.09 x 1.833 x 0.1443 x 0.1282 x - 0.1779 x 0.1608 x
Free Cash Flow 1 -126 -118 -106 118 -29.8 -194 -278 151
ROE (net income / shareholders' equity) 9.71% -2.65% 4.87% 24.4% 17.7% 2.68% 4.92% 8.92%
ROA (Net income/ Total Assets) 6.62% -2.1% 0.06% 16.7% 12.4% 14.4% 6.95% 11.4%
Assets 1 757.9 898.2 1,070 1,638 2,652 1,909 8,218 8,196
Book Value Per Share 2 1.550 1.610 1.850 2.970 10.90 6.290 6.520 7.150
Cash Flow per Share 2 0.1600 0.0200 0.0600 0.9400 1.420 0.3700 0.4200 0.6500
Capex 1 189 124 132 337 327 630 743 660
Capex / Sales 48.66% 43.03% 31.37% 41.43% 37.07% 48.68% 40.54% 26.26%
Announcement Date 2/20/20 2/18/21 2/17/22 2/14/23 2/22/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for LIVENT

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
20
Last Close Price
3.88 USD
Average target price
8.223 USD
Spread / Average Target
+111.94%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Specialty Chemicals

1st Jan change Capi.
ECOLAB INC. Stock Ecolab Inc.
+11.47% 63.22B
SIKA AG Stock Sika AG
-3.47% 46.34B
GIVAUDAN SA Stock Givaudan SA
+13.72% 39.97B
FUJIFILM HOLDINGS CORPORATION Stock Fujifilm Holdings Corporation
+17.83% 25.46B
EMS-CHEMIE HOLDING AG Stock EMS-CHEMIE HOLDING AG
+7.27% 18.68B
CELANESE CORPORATION Stock Celanese Corporation
-0.57% 17.24B
POSCO FUTURE M CO., LTD. Stock Posco Future M Co., Ltd.
-21.73% 15.81B
SYMRISE AG Stock Symrise AG
+0.22% 14.9B
ALBEMARLE CORPORATION Stock Albemarle Corporation
-19.10% 13.74B
Other Specialty Chemicals
  1. Stock Market
  2. Equities
  3. ALTM Stock
  4. LTHM Stock
  5. Financials LIVENT